Clinical trial
PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue
NCT00490555 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00490555 |
|---|---|
| Title | PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue |
| Official title | The Effect of Male Hormonal Contraceptive Regimens on Prostate Tissue In Normal Men |
| Acronym | PROS-1 |
| Lead sponsor | University of Washington, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug, Other |
| Interventions | Testosterone gel, Dutasteride, Depo-Medroxyprogesterone (DMPA), Placebo Testosterone gel, Placebo dutasteride, Placebo DMPA |
| Enrollment | 32 |
| Start date | Jan 1, 2009 |
| Primary completion | Jan 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | Jun 22, 2007 |
| Last update posted | Nov 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: